Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine type.
Adams
M
M
University Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield, U.K.
Lennard
M S
MS
Otton
S V
SV
Tucker
G T
GT
Woods
H F
HF
D000818:Animals; D003647:Debrisoquin / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D008790:Metoprolol / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008811:Mice, Inbred DBA; D008814:Mice, Inbred NZB; D008815:Mice, Inbred Strains / Q000235:genetics / Q000378:metabolism*; D008862:Microsomes, Liver / Q000378:metabolism; D008954:Models, Biological; D010084:Oxidation-Reduction; D010641:Phenotype; D011110:Polymorphism, Genetic / Q000502:physiology*; D013034:Sparteine / Q000378:metabolism*
D013034:Sparteine; D008790:Metoprolol; D003647:Debrisoquin